Tasly Pharmaceutical Group Co., Ltd

This study tested a new drug called STRO-002 in Chinese adults with advanced solid tumors, including ovarian and endometrial cancer, that had stopped responding to standard treatments. The main goals were to find a safe dose, see how the body processes the drug, and check for ear…

This study tested a drug called pimavanserin to see if it safely reduces hallucinations and delusions in people with Parkinson's disease. 248 adults aged 40 and older with Parkinson's-related psychosis took either the drug or a placebo for 43 days. The goal was to measure how muc…

This study tested a new drug called JS1-1-01 in 267 adults with moderate to severe depression. The goal was to see if it safely reduces depression symptoms better than a placebo. Researchers measured changes using standard depression rating scales.

This study tested whether Qingzhu Granules can safely reduce pain in adults with acute gouty arthritis. 472 participants with a current flare-up took the granules or a placebo. The main goal was to measure pain relief within 72 hours using a standard pain scale.